Who needs more than two employees when artificial intelligence can do so many corporate tasks? It’s super efficient — and a ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough.

After a brief pause in communications with Voyager 1, NASA re-established a connection with the interstellar spacecraft located more than 15 billion miles away from Earth, using a frequency not used ...

The Dwingeloo telescope, designed to observe signals at low frequencies, detected the farthest human spacecraft when it went dark earlier this year. Reading time 2 minutes Voyager 1 is currently ...

The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

Share on Pinterest An increasing number of people without diabetes are using GLP-1 agonist drugs for weight loss only. Image credit: MarkHatfield/Getty Images. The last few years have seen a marked ...

A majority of people with overweight or obesity prescribed glucagon-like peptide 1 receptor agonists (GLP-1 RAs) discontinue them within 1 year, with higher quit rates among those without type 2 ...

Preliminary evidence suggests women who took GLP-1s before conceiving actually had healthier pregnancies compared to women ...